Shingles

Latest News

JAK Inhibitors May Increase Risk of Shingles in Patients With Immune-Mediated Inflammatory Diseases
JAK Inhibitors May Increase Risk of Shingles in Patients With Immune-Mediated Inflammatory Diseases

October 10th 2023

Patients with rheumatoid arthritis had a higher risk of shingles when treated once a day with 4 mg of baricitinib, 100 mg of peficitinib, or 30 mg of upadacitinib.

Gaps in RZV Knowledge, Practice Among Specialty Health Care Providers Remain
Gaps in RZV Knowledge, Practice Among Specialty Health Care Providers Remain

December 5th 2022

No Association Between mRNA COVID-19 and Herpes Zoster Identified
No Association Between mRNA COVID-19 and Herpes Zoster Identified

June 1st 2022

Patients With Cancer at Greater Risk for Shingles
Patients With Cancer at Greater Risk for Shingles

May 31st 2022

Shingrix Guidelines for the Immunocompromised
Shingrix Guidelines for the Immunocompromised

April 15th 2022

Latest CME Events & Activities

Treatment Advancements and Management Strategies in Bipolar Disorder to Mitigate Challenges to Patient Care

1.0 Credit / Neurology, Psychiatry

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

A Managed Care Focus on Assessing the Armamentarium for Multiple Sclerosis to Better Individualize Treatment

1.5 Credits / Neurology

View More

The Value of Early Intervention With Long-Acting Injectable Antipsychotics to Improve Adherence and Treatment of Schizophrenia

1.5 Credits / Neurology, Psychiatry

View More

The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights

1.0 Credit / Neurology

View More

Understanding the Role of IVIg and SCIg for the Management of CIDP: Information the Pharmacist Needs to Know to Optimize Care, featuring a Patient Perspective

1.5 Credits / Immunology, Neurology

View More

Rare and Treatment-Resistant Epilepsy Syndromes: Identifying and Addressing the Unmet Needs of Patients and Recognizing Opportunities for Pharmacist Intervention

1.5 Credits / Neurology

View More

Reducing Barriers Associated With Pneumococcal Vaccine Uptake

1.5 Credits / Immunization, Infectious Diseases

View More

Strategies for the Management and Treatment of ALS: The Value of Early Diagnosis and Clinical Intervention

3.0 Credits / Neurology

View More

Reducing the Incidence and Severity of RSV in Older Adults: Opportunities for Patient Identification and Vaccination Counseling

1.0 Credit / Infectious Diseases, Pulmonology/Respiratory

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

1.0 Credit / Neurology

View More

Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances

2.0 Credits / Neurology

View More

Examining the Evidence for Emerging Vaccines to Prevent RSV-Related Complications in Older Adults

2.0 Credits / Infectious Diseases, Respiratory, Immunization

View More

Navigating the Use of Targeted Therapies and Individualizing Care for Patients With Ulcerative Colitis

1.5 Credits / Gastroenterology

View More

New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist

1.0 Credit / Neurology

View More

Influenza Prevention in the At-Risk Adult Population and the Pharmacist's Role in an Evolving Influenza Vaccine Landscape

1.25 Credits / Immunization, Infectious Disease

View More

Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden

1.5 Credits / Neurology

View More

Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care

1.5 Credits / Neurology

View More

Advances in Pharmacotherapy for Excessive Daytime Sleepiness Due to Narcolepsy

2.0 Credits / Neurology

View More

The Role of Long-Term Care and Consultant Pharmacists in the Management of Tardive Dyskinesia

1.0 Credit / Neurology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

More News

© 2024 MJH Life Sciences

All rights reserved.